News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Polartechnics (PLT) Enters Global Sexually Transmitted Infection (STI) Market With A DNA Self-Sampling Device



2/18/2009 12:39:05 PM

Sydney, Feb 18, 2009 (ABN Newswire) - Polartechnics Limited (ASX:PLT)(PINK:PLTFF) proprietary self-sampling device, CerviScreen, has now been adapted to test for STI's including Chlamydia, Gonorrhoea and Trichomoniasis for both men and women. The new self-sampling target market for the STI device is sexually active men and women aged 15 to 50.

Read at ABN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES